The second season of the Keck School of Medicine Dean’s Distinguished Lecturer Series will feature Robert A. Bradway, chair and CEO of Amgen, the world’s largest independent biotechnology company.

Bradway will speak at 4 p.m. on Aug.13 in Mayer Auditorium on USC’s Health Sciences Campus.

Bradway became chairman in January 2013 and chief executive officer in May 2012. He served as the company’s president and chief operating officer from May 2010 to May 2012 and was appointed to the Amgen Board of Directors in October 2011. He joined the company in 2006 as vice president of operations strategy, and served as executive vice president and chief financial officer from April 2007 to May 2010.

Prior to joining Amgen, he was a managing director at Morgan Stanley in London where he had responsibility for the firm’s banking department and corporate finance activities in Europe. Bradway holds a bachelor’s degree in biology from Amherst College and a master’s degree in business administration from Harvard University. In addition to being a USC trustee, he serves on the advisory board of USC’s Leonard D. Schaeffer Center for Health Policy and Economics.

To attend, RSVP online at (code: Bradway).

The even will be webcast live at